This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Metriopharm Ag. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Maliha Shah: Innovator in Multiple Sclerosis Treatment
Introduction
Maliha Shah is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of medicine, particularly in the treatment of chronic progressive multiple sclerosis. Her innovative approach has garnered attention in the scientific community.
Latest Patents
Maliha Shah holds a patent for the use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the treatment of chronic progressive multiple sclerosis. This invention relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione or related compounds, compositions, or combinations thereof, specifically targeting primary and secondary progressive multiple sclerosis. The patent emphasizes the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt for these therapeutic purposes. She has 1 patent to her name.
Career Highlights
Maliha Shah is currently associated with Metriopharm AG, where she continues her research and development efforts. Her work focuses on innovative treatments that can improve the quality of life for patients suffering from chronic conditions.
Collaborations
Maliha collaborates with esteemed colleagues such as Wolfgang Brysch and Beate Ludescher. Their combined expertise enhances the research and development processes at Metriopharm AG.
Conclusion
Maliha Shah is a trailblazer in the field of medical innovation, particularly in the treatment of multiple sclerosis. Her contributions are paving the way for new therapeutic options that could significantly benefit patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile